Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.

BMC cancer（2018）

引用 65|浏览34

暂无评分

摘要

ClinicalTrials.gov : NCT02047513, 08/13/2014.

查看译文

关键词

Pancreatic ductal adenocarcinoma,Pancreatic cancer,Resectable,Neoadjuvant chemotherapy,Perioperative chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要